Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products

Dáil Éireann Debate, Tuesday - 9 July 2024

Tuesday, 9 July 2024

Ceisteanna (789)

Alan Dillon

Ceist:

789. Deputy Alan Dillon asked the Minister for Health the reason there is a shortage of tyvense medication, which is used to treat conditions such as a ADHD; the measures his Department is taking to ensure an adequate supply of this vital medication; and if he will make a statement on the matter. [29828/24]

Amharc ar fhreagra

Freagraí scríofa

The supplier of Tyvense (Takeda Pharmaceuticals) has advised that as of 8th July 2024 there are no current shortages of any presentation of Tyvense® (available as 20mg hard capsules, 30mg hard capsules, 40mg hard capsules, 50mg hard capsules, 60mg hard capsules, 70mg hard capsules) in Ireland.

The Health Products Regulatory Authority (HPRA) hosts a list of current and resolved shortages on its website, where relevant details of shortages are maintained. The webpage is updated daily as the HPRA receives new information.

Roinn